Metrics to compare | 688046 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688046PeersSector | |
|---|---|---|---|---|
P/E Ratio | 59.4x | 41.4x | −0.4x | |
PEG Ratio | 1.27 | 0.31 | 0.00 | |
Price/Book | 4.2x | 3.1x | 2.6x | |
Price / LTM Sales | 11.4x | 5.3x | 3.0x | |
Upside (Analyst Target) | 16.5% | 19.1% | 49.1% | |
Fair Value Upside | Unlock | 10.1% | 6.3% | Unlock |
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.